Skip to main content
SpringerLink
Log in
Book cover

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases pp 325–382Cite as

Potential Therapeutic Strategies for Neurodegenerative Diseases

  • Chapter
  • First Online:

Abstract

Neurodegenerative diseases include Alzheimer disease (AD), Parkinson disease (PD), Huntington disease (HD), amyotrophic lateral sclerosis (ALS), and prion diseases. The primary causes of neurodegenerative diseases are not known.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, Leroi I, Pozo-Rodriguez F, Minthon L, Londos E (2009) Memantine in patients with Parkinson’s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol 8:613–618

    Article  PubMed  CAS  Google Scholar 

  • Adlerz L, Holback S, Multhaup G, Iverfeldt K (2009) IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways. J Biol Chem 282:10203–10209

    Article  CAS  Google Scholar 

  • Aguzzi A, Baumann F, Bremer J (2008) The prion’s elusive reason for being. Ann Rev Neurosci 31:439–477

    Article  PubMed  CAS  Google Scholar 

  • Alexandrenne C, Hanoux V, Dkhissi F, Boquet D, Couraud JY, Wijkhuisen A (2009) Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies. J Neuroimmunol 209:50–56

    Article  PubMed  CAS  Google Scholar 

  • Andreassen OA, Dedeoglu A, Ferrante RJ, Jenkins BG, Ferrante KL, Thomas M, Friedlich A, Browne SE, Schilling G, Borchelt DR, Hersch SM, Ross CA, Beal MF (2001) Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington’s disease. Neurobiol Dis 8:479–491

    Article  PubMed  CAS  Google Scholar 

  • Avramovich-Tirosh Y, Reznichenko L, Mit T, Zheng H, Fridkin M, Weinreb O, Mandel S, Youdim MB (2007) Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron-chelating-antioxidants, M-30 and green tea polyphenol, EGCG. Curr Alzheimer Res 4:403–411

    Article  PubMed  CAS  Google Scholar 

  • Bandyopadhyay S, Goldstein LE, Lahiri DK, Rogers JT (2007) Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer’s disease. Curr Med Chem 14:2848–2864

    Article  PubMed  CAS  Google Scholar 

  • Bartke A, Bonkowski M, Masternak M (2008) Thow diet interacts with longevity genes. Hormones 7:17–23

    PubMed  Google Scholar 

  • Bate C, Tayebi M, Diomede L, Salmona M, Williams A (2009) Glimepiride reduces the expression of PrP, prevents PrP formation and protects against prion mediated neurotoxicity in cell lines. PLoS One 4(12):e8221

    Article  PubMed  CAS  Google Scholar 

  • Bauer PO, Wong HK, Oyama F, Goswami A, Okuno M, Kino Y, Miyazaki H, Nukina N (2009) Inhibition of rho kinases enhances the degradation of mutant huntingtin. J Biol Chem 284:13153–13164

    Article  PubMed  CAS  Google Scholar 

  • Bazan NG (2005) Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 15:159–166

    Article  PubMed  CAS  Google Scholar 

  • Bazan NG (2006) The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling. Cell Mol Neurobiol 26:901–913

    Article  PubMed  CAS  Google Scholar 

  • Bazan NG (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 10:136–141

    Article  PubMed  CAS  Google Scholar 

  • Beal MF (2009) Therapeutic approaches to mitochondrial dysfunction in Parkinson’s disease. Parkinsonism Relat Disord 15(Suppl 3):S189–S194

    Article  PubMed  Google Scholar 

  • Benoit E, Escande D (1991) Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflugers Arch 419:603–609

    Article  PubMed  CAS  Google Scholar 

  • Benesimon G, Lacomblez L, Meininger V (1994) A controlled trial of riluzole in amyotrophic lateral sclerosisALS/Riluzole Study Group. N Engl J Med 330:585–591

    Article  Google Scholar 

  • Bilsland LG, Greensmith L (2008) The endocannabinoid system in amyotrophic lateral sclerosis. Curr Pharm Des 14:2306–2316

    Article  PubMed  CAS  Google Scholar 

  • Birks J (2006) Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev (1):CD005593

    Google Scholar 

  • Bonelli RM, Hodl AK, Hofmann P, Kapfhammer HP (2004) Neuroprotection in Huntington’s disease: a 2-year study on minocycline. Int Clin Psychopharmacol 19:337–342

    Article  PubMed  Google Scholar 

  • Bonini NM, La Spada AR (2005) Silencing polyglutamine degeneration with RNAi. Neuron 48:715–718

    Article  PubMed  CAS  Google Scholar 

  • Bousquet M, Saint-Pierre M, Julien C, Salem N Jr., Cicchetti F, Calon F (2008) Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson’s disease. FASEB J 22:1213–1225

    Article  PubMed  CAS  Google Scholar 

  • Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC (2002) Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson’s disease. J Neurochem 82:615–624

    Article  PubMed  CAS  Google Scholar 

  • Bu G (2009) Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333–344

    Article  PubMed  CAS  Google Scholar 

  • Bueler H (2009) Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson’s disease. Exp Neurol 218:235–246

    Article  PubMed  CAS  Google Scholar 

  • Buisson B, Bertrand D (1998) Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 53:555–563

    PubMed  CAS  Google Scholar 

  • Calon F, Lim GP, Yang FS, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem NJ, Ashe KH, Frautschy SA, Cole GM (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model. Neuron 43:633–645

    Article  PubMed  CAS  Google Scholar 

  • Calon F, Cole G (2007) Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prost Leukot Essent Fatty Acids 77:287–293

    Article  CAS  Google Scholar 

  • Carro E, Trejo JL, Busiguina S, Torres-Aleman I (2001) Circulating insulin-like growth factor I mediates the protective effects of physical exercise. J Neurosci 21:5678–5684

    PubMed  CAS  Google Scholar 

  • Carro E, Torres-Aleman I (2004) The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer’s disease. Eur J Pharmacol 490:127–133

    Article  PubMed  CAS  Google Scholar 

  • Chaturvedi RK, Beal MF (2008) PPAR: a therapeutic target in Parkinson’s disease. J Neurochem 106:506–518

    Article  PubMed  CAS  Google Scholar 

  • Chauhan NB, Siegel GJ (2004) Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer’s disease. Expert Rev Vaccines 3:717–725

    Article  PubMed  CAS  Google Scholar 

  • Chen M, Ona VO, Li M, Ferrante RJ, Fink KB (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797–801

    Article  PubMed  CAS  Google Scholar 

  • Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A (2005) Nonsteroidal anti-inflammatory drug use and the risk for Parkinson’s disease. Ann Neurol 58:963–967

    Article  PubMed  CAS  Google Scholar 

  • Chen MJ, Russo-Neustdt AA (2007) Running exercise- and antidepressant-induced increases in growth and survival-associated signaling molecules are IGF-dependent. Growth Factor 25:118–131

    Article  CAS  Google Scholar 

  • Chen JX, Yan SD (2007a) Amyloid-beta-induced mitochondrial dysfunction. J Alzheimer Dis 12:177–184

    CAS  Google Scholar 

  • Chen JX, Yan SD (2007b) Pathogenic role of mitochondrial [correction of mitochondrial] amyloid-beta peptide. Expert Rev Neurother 7:1517–1525

    Article  PubMed  CAS  Google Scholar 

  • Chen Y, Meiminger V, Guillemin GJ (2009) Recent advances in the treatment of amyotrophic lateral sclerosis emphasis on kynurenine pathway inhibitors. Cent Nerv Syst Agents Med Chem 9:32–39

    Article  PubMed  CAS  Google Scholar 

  • Chéramy A, Barbeito L, Godeheu G, Glowinski J (1992) Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci Lett 147:209–212

    Article  PubMed  Google Scholar 

  • Cole GM, Ma QL, Frautschy SA (2009) Omega-3 fatty acids and dementia. Prost Leukot Essent Fatty Acids 81:213–221

    Article  CAS  Google Scholar 

  • Coppede F, Mancuso M, Siciliano G, Migliore L, Murri L (2006) Genes and the environment in neurodegeneration. Biosci Rep 26:341–367

    Article  PubMed  CAS  Google Scholar 

  • Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr., Rimmler JB, Locke PA, Conneally PM, Schmader KE (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7:180–184

    Article  PubMed  CAS  Google Scholar 

  • Cordle A, Landreth G (2005) 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate β-amyloid-induced microglial inflammatory responses. J Neurosci 25:299–307

    Article  PubMed  CAS  Google Scholar 

  • Cordle A, Koenigsknecht-Talboo J, Wilkinson B, Limpert A, Landreth G (2005) Mechanisms of statin-mediated inhibition of small G-protein function. J Biol Chem 280:34202–34209

    Article  PubMed  CAS  Google Scholar 

  • Cotman CW (2005) The role of neurotrophins in brain aging: a perspective in honor of Regino Perez-Polo. Neurochem Res 30:877–881

    Article  PubMed  CAS  Google Scholar 

  • Das VN, Vaddadi KS (2004) Essential fatty acids in Huntington’s disease. Nutrition 20:942–947

    Article  PubMed  CAS  Google Scholar 

  • Dealler S, Rainov NG (2003) Pentosan polysulfate as a prophylactic and therapeutic agent against prion disease. IDrugs 6:470–478

    PubMed  CAS  Google Scholar 

  • Dehmer T, Heneka MT, Sastre M, Dichgans J, Schulz JB (2004) Protection by pioglitazone in the MPTP model of Parkinson’s disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J Neurochem 88:494–501

    Article  PubMed  CAS  Google Scholar 

  • Delattre AM, Kiss A, Szawka RE, Anselmo-Franci JA, Bagatini PB, Xavier LL, Rigon P, Achaval M, Iagher F, de David C, Marroni NA, Ferraz AC (2009) Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson’s disease. Neurosci Res 24 Nov 2009 [Epub ahead of print]

    Google Scholar 

  • de Oliveria DM, Barreto G, De Anrade DV, Dos El Bacha R, Goraldez LD (2009) Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease. Neurochem Res 34:215–220

    Article  PubMed  CAS  Google Scholar 

  • Ding O, Vaynman S, Akhavan M, Ying Z, Gomez-Pinilla F (2006) Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience 140:823–833

    Article  PubMed  CAS  Google Scholar 

  • Doble A, Hubert JP, Blanchard JC (1992) Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells. Neurosci Lett 140:251–254

    Article  PubMed  CAS  Google Scholar 

  • Doh-ura K (2004) Prion diseases: disease diversity and therapeutics. Rinsho Shinkeigaku 44:855–856

    PubMed  Google Scholar 

  • Doh-ura K (2009) Innovation of therapeutics and prophylaxis for prion diseases. Rinsho Shinkeigaku 49:946–948

    Article  PubMed  Google Scholar 

  • Eibl JK, Chapelsky SA, Ross GM (2010) Multipotent neurotrophin antagonist targets brain-derived neurotrophic factor and nerve growth factor. J Pharmacol Exp Ther 332:446–454

    Article  PubMed  CAS  Google Scholar 

  • Endres M (2005) Statins and stroke. J Cereb Blood Flow Metab 25:1093–1110

    Article  PubMed  CAS  Google Scholar 

  • Esposito E, Di Matteo V, Benigno A, Pierucci M, Crescimanno G, Di Giovanni G (2007) Non-steroidal anti-inflammatory drugs in Parkinson’s disease. Exp Neurol 205:295–312

    Article  PubMed  CAS  Google Scholar 

  • Falls DL (2003) Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284:14–30

    Article  PubMed  CAS  Google Scholar 

  • Farooqui AA, Horrocks LA (2007) Glycerophospholipids in the brain: phospholipases A2 in neurological disorders. Springer, New York, NY, pp 1–394

    Google Scholar 

  • Farooqui AA, Horrocks LA, Farooqui T (2007a) Modulation of inflammation in brain: a matter of fat. J Neurochem 101:577–599

    Article  PubMed  CAS  Google Scholar 

  • Farooqui AA, Ong WY, Horrocks LA, Chen P, Farooqui T (2007b) Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. Brain Res Rev 56:443–471

    Article  PubMed  CAS  Google Scholar 

  • Farooqui AA (2009a) Hot topics in neural membrane lipidology. Springer, New York, NY

    Book  Google Scholar 

  • Farooqui AA (2009b) Beneficial effects of fish oil on human brain. Springer, New York, NY

    Book  Google Scholar 

  • Farooqui T, Farooqui AA (2009) Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev 130:203–215

    Article  PubMed  CAS  Google Scholar 

  • Ferrante RJ, Andreassen OA, Jenkins BG, Dedeoglu A, Kuemmerle S, Kubilus JK, Kaddurah-Daouk R, Hersch SM, Beal MF (2000) Neuroprotective effects of creatine in a transgenic mouse model of Huntington’s disease. J Neurosci 20:4389–4397

    PubMed  CAS  Google Scholar 

  • Farrelly PV, Kenna BL, Laohachai KL, Bahadi R, Salmona M, Forloni G, Kourie JI (2003) Quinacrine blocks PrP (106–126)-formed channels. J Neurosci Res 74:934–941

    Article  PubMed  CAS  Google Scholar 

  • Fisher A (2007) M1 muscarinic agonists target major hallmarks of Alzheimer’s disease – an update. Curr Alzheimer Dis 4:577–580

    Article  CAS  Google Scholar 

  • Follette P (2003) New perspectives for prion therapeutics meeting Prion disease treatment’s early promise unravels. Science 299:191–192

    Article  PubMed  CAS  Google Scholar 

  • Fontan-Lozano A, Lopez-lluch G, Delgado-Garcia JM, Navas P, Carrion AM (2008) Molecular bases of caloric restriction regulation of neuronal synaptic plasticity. Mol Neurobiol 38:167–177

    Article  PubMed  CAS  Google Scholar 

  • Fratiglioni L, Qiu C (2009) Prevention of common neurodegenerative disorders in the elderly. Exp Gerontol 44:46–50

    Article  PubMed  Google Scholar 

  • Freude S, Hettich MM, Schumann C, Stohr O, Koch L, Kohler C, Udelhoven M, Leeser U, Muller M, Kubota N, Kadowaki T, Krone W, Schroder H, Bruning JC, Schubert M (2009a) Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer’s disease. FASEB J 23:3315–3324

    Article  PubMed  CAS  Google Scholar 

  • Freude S, Schilbach K, Schubert M (2009b) The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer’s disease: from model organisms to human disease. Curr Alzheimer Res 6:213–223

    Article  PubMed  CAS  Google Scholar 

  • Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 63:1402–1408

    Article  PubMed  Google Scholar 

  • Frisardi V, Solfrizzi V, Imbimbo BP, Capurso C, D‘Introno A, Colacicco AM, Vendemiale G, Seripa D, Pilotto A, Capurso A, Panza F (2009) Towards disease-modifying treatment of alzheimer’s disease: drugs targeting beta-amyloid. Curr Alzheimer Res 26 Nov 2009 [Epub ahead of print]

    Google Scholar 

  • Fuenzalida K, Quintanila R, Ramos P, Pident D, Fuentealba RA, Martinez G, Inestrosa NC, Bronfman M (2007) Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J Biol Chem 282:37006–37015

    Article  PubMed  CAS  Google Scholar 

  • Ghosh A, Kumaragurubaran N, Tang J (2005) Recent developments of structure-based β-secretase inhibitor’s for Alzheimer’s disease. Curr Top Med Chem 5:1609–1622

    Article  PubMed  CAS  Google Scholar 

  • Ghosh S, Novak EM, Innis SM (2007) Cardiac proinflammatory pathways are altered with different dietary n-6 linoleic to n-3 α-linolenic acid ratios in normal, fat-fed pigs. Am J Physiol Heart Circ Physiol 293:H2919–H2927

    Article  PubMed  CAS  Google Scholar 

  • Ghosh A, Roy A, Matras J, Brahmchari S, Gendelman HE, Pahan K (2009) Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson’s disease. J Neurosci 29:13543–13556

    Article  PubMed  CAS  Google Scholar 

  • Gilgun-Sherki Y, Melamed E, Offen D (2006) Anti-inflammatory drugs in the treatment of neurodegenerative diseases: current state. Curr Pharmaceut Des 12:3509–3519

    Article  CAS  Google Scholar 

  • Gozes I, Morimoto BH, Tiong J, Fox A, Sutherland K, Dangoor D, Holser-Cochav M, Vered K, Newton P, Aisen PS, Matsuoka Y, van Dyck CH, Thal L (2005) NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). CNS Drug Rev 11:353–368

    Article  PubMed  CAS  Google Scholar 

  • Gozes I (2007) Activity-dependent neuroprotective protein: from gene to drug candidate. Pharm Therp 114:146–154

    Article  CAS  Google Scholar 

  • Gozes I, Stewart A, Morimoto B, Fox A, Sutherland K, Schmeche D (2009) Addressing Alzheimer’s disease tangles: from NAP to AL-108. Curr Alzheimer Res 6:455–460

    Article  PubMed  CAS  Google Scholar 

  • Graeber MB, Moran LB (2002) Mechanisms of cell death in neurodegenerative diseases: fashion, fiction, and facts. Brain Pathol 12:385–390

    Article  PubMed  Google Scholar 

  • Greulich W, Fenger E (1995) J Neural Transm 46(Suppl):415–421

    CAS  Google Scholar 

  • Joseph JA, Shukitt-Hale B, Lau FC (2007) Fruit polyphenols and their effects on neuronal signaling and behavior in senescence. Ann NY Acad Sci 1100:470–485

    Article  PubMed  CAS  Google Scholar 

  • Guentchev M, Voigtlander T, Haberler C, Groschup MH, Budka H (2000) Evidence for oxidative stress in experimental prion disease. Neurobiol Dis 7:270–273

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto M, Hossain S, Agdul H, Shido O (2005) Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions. Biochim Biophys Acta 1738:91–98

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto M, Hossain S, Shimada T, Shido O (2006) Docosahexaenoic acid-induced protective effect against impaired learning in amyloid β-infused rats is associated with increased synaptosomal membrane fluidity. Clin Exp Pharmacol Physiol 33:934–939

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto M, Shahdat HM, Yamashita S, Katakura M, Tanabe Y, Fujiwara H, Gamoh S, Miyazawa T, Arai H, Shimada T, Shido O (2008) Docosahexaenoic acid disrupts in vitro amyloid beta fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer’s disease model rats. J Neurochem 107:1634–1646

    Article  PubMed  CAS  Google Scholar 

  • Heneka MT, Landreth GE (2007) PPARs in the brain. Biochim Biophys Acta 1771:1031–1045

    Article  PubMed  CAS  Google Scholar 

  • Heneka MT, Landreth GE, Hull M (2007) Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders. Nat Clin Pract Neurol 3:496–504

    Article  PubMed  CAS  Google Scholar 

  • Heppner FL, Aguzzi A (2004) Recent developments in prion immunotherapy. Curr Opin Immunol 16:594–598

    Article  PubMed  CAS  Google Scholar 

  • Herzog CD, Brown L, Gammon D, Kruegel B, Lin R, Wilson A, Bolton A, Printz M, Gasmi M, Bishop KM, Kordower JH, Bartus RT (2009) Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson’s disease. Neurosurgery 64:602–612

    Article  PubMed  Google Scholar 

  • Hirohata M, Ono K, Yamada M (2008) Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds. Curr Pharm Des 14:3280–3294

    Article  PubMed  CAS  Google Scholar 

  • Hong M, Mukhida K, Mendez I (2008) GDNF therapy for Parkinson’s disease. Expert Rev Neurother 8:1125–1139

    Article  PubMed  CAS  Google Scholar 

  • Hooper NM, Turner AJ (2002) The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer’s disease. Curr Med Chem 9:1107–1119

    Article  PubMed  CAS  Google Scholar 

  • Hoyer S (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490:115–125

    Article  PubMed  CAS  Google Scholar 

  • Howe CL, Vergstrom RA, Horazdovsky BF (2009) Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 73:1247

    Article  PubMed  Google Scholar 

  • Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS, Murphy KE, Southan CD, Ryan DM, Smith TS, Simmons DL, Walsh FS, Dingwall C, Christie G (1999) Identification of a novel aspartic protease (Asp2) as β-secretase. Mol Cell Neurosci 14:419–427

    Article  PubMed  CAS  Google Scholar 

  • Ikemoto A, Nitta A, Furukawa S, Ohishi M, Nakamura A, Fujii Y, Okuyama H (2000) Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci Lett 285:99–102

    Article  PubMed  CAS  Google Scholar 

  • Jacobsen KT, Adlerz L, Multhaup G, Iverfeldt K (2010) Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-{beta} precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases. J Biol Chem 5 Feb 2010 [Epub ahead of print]

    Google Scholar 

  • Jankovic J, Stacy M (2007) Medical management of levodopa-associated motor complications in patients with Parkinson’s disease. CNS Drugs 21:677–692

    Article  PubMed  CAS  Google Scholar 

  • Jeng BH, Galor A, Lee MS, Meisler DM, Hellyfield JG (2008) Amantadine-associated corneal edema potentially irreversible even after cessation of the medication. Opthalmology 115:1540–1544

    Article  Google Scholar 

  • Ji Y, Pang PT, Feng L, Lu B (2005) Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons. Nat Neurosci 8:164–172

    Article  PubMed  CAS  Google Scholar 

  • Jiang Q, Heneka M, Landreth GE (2008) The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer’s disease: therapeutic implications. CNS Drugs 22:1–14

    Article  PubMed  CAS  Google Scholar 

  • Jin H, Randazzo J, Zhang P, Kador PF (2010) Multifunctional antioxidants for the treatment of age-related diseases. J Med Chem 53:1117–1127

    Article  PubMed  CAS  Google Scholar 

  • Kalinin S, Richardson JC, Feinstein DL (2009) A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer’s disease. Curr Alzheimer Res 6:431–437

    Article  PubMed  CAS  Google Scholar 

  • Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42:776–782

    Article  PubMed  CAS  Google Scholar 

  • Kaufer D, Gandy S (2009) APOE {epsilon}4 and bapineuzumab: infusing pharmacogenomics into Alzheimer disease therapeutics. Neurology 73:2052–2053

    Article  PubMed  Google Scholar 

  • Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, Katz J, Rollins Y, Barohn RJ, Jackson CE, et al (2009) Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol 66:235–244

    Article  PubMed  CAS  Google Scholar 

  • Kidd PM (2005) Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. Altern Med Rev 10:268–293

    PubMed  Google Scholar 

  • Kobayashi Y, Hirata K, Tanaka H, Yamada T (2003) Quinacrine administration to a patient with Creutzfeldt-Jakob disease who received a cadaveric dura mater graft – an EEG evaluation. Rinsho Shinkeigaku 43:403–408

    PubMed  Google Scholar 

  • Kobayashi M, Kim J, Kobayashi N, Han S, Nakamura C, Ikebukuro K, Soda K (2006) Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein. Biochem Biophys Res Commun 349:1139–1144

    Article  PubMed  CAS  Google Scholar 

  • Kojro E, Fahrenholz F (2005) The non-amyloidogenic pathway: structure and function of alpha-secretases. Subcell Biochem 38:105–127

    Article  PubMed  CAS  Google Scholar 

  • Koob AO, Ubhi K, Paulsson JF, Kelly J, Rockenstein E, Mante M, Adame A, Masliah E (2010) Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies. Exp Neurol 221:267–274

    Article  PubMed  CAS  Google Scholar 

  • Korth C, May BC, Cohen FE, Prusiner SB (2001) Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 98:9836–9841

    Article  PubMed  CAS  Google Scholar 

  • Kummer MP, Heneka MT (2008) PPARs in Alzheimer’s disease. PPAR Res 2008

    Google Scholar 

  • Lacomblez L, Bensiman G, Leigh PN, Guillet P, Meininger V (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347:1425–1431

    PubMed  CAS  Google Scholar 

  • Lahiri DK, Maloney B, Basha MR, Ge YW, Zawia NH (2007) How and when environmental agents and dietary factors affect the course of Alzheimer’s disease: the “LEARn” model (latent early-life associated regulation) may explain the triggering of AD. Curr Alzheimer Res 4:219–228

    Article  PubMed  CAS  Google Scholar 

  • Lai A, Frishman WH (2005) Rho-kinase inhibition in the therapy of cardiovascular disease. Cardiol Rev 13:285–292

    Article  PubMed  Google Scholar 

  • Landreth G, Jiang Q, Mandrekar S, Henecka M (2008) PPARgamma agonists as therapeutics for the treatment of Alzheimer’s disease. Neurotherapeutics 5:481–489

    Article  PubMed  CAS  Google Scholar 

  • Lau FC, Shukitt-Hale B, Joseph JA (2007) Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress. Subcell Biochem 42:299–318

    Article  PubMed  Google Scholar 

  • Lee J, Duan W, Long JM, Ingram DK, Mattson MP (2000) Dietary restriction increases the number of newly generated neural cells, and induces BDNF expression, in the dentate gyrus of rats. J Mol Neurosci 15:99–108

    Article  PubMed  CAS  Google Scholar 

  • Lemere CA, Mair M, Peng Y, Jiang L, Seabrook T (2007) Novel Abeta immunogens: is shorter better? Curr Alzheimer Res 4:427–436

    Article  PubMed  CAS  Google Scholar 

  • Lemere CA (2009) Developing novel immunogens for a safe and effective Alzheimer’s disease vaccine. Prog Brain Res 175:83–93

    Article  PubMed  CAS  Google Scholar 

  • Leroi I, Overshott R, Byrne EJ, Daniel E, Burns A (2009) Randomized controlled trial of memantine in dementia associated with Parkinson’s disease. Mov Disord 24:1217–1221

    Article  PubMed  Google Scholar 

  • Levy G, Kaufmann P, Buchsbaum R, Montes J, Barsdorf A, Arbing R, Battista V, Zhou X, Mitsumoto L, Levin B, Thompson JL (2006) A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS. Neurology 66:660–663

    Article  PubMed  CAS  Google Scholar 

  • Li L, Tang BL (2005) Environmental enrichment and neurodegenerative diseases. Biochem Biophys Res Commun 334:293–297

    Article  PubMed  CAS  Google Scholar 

  • Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, Salem N Jr, Frautschy SA, Cole GM (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25:3032–3040

    Article  PubMed  CAS  Google Scholar 

  • Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J (2000) Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein. Proc Natl Acad Sci USA 97:1456–1460

    Article  PubMed  CAS  Google Scholar 

  • Lindvall O, Wahlberg LU (2008) Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson’s disease? Exp Neurol 209:82–88

    Article  PubMed  CAS  Google Scholar 

  • Lipton SA, Choi YB, Takahashi H, Zhang D, Li W, Godzik A, Bankston LA (2002) Cysteine regulation of protein function – as exemplified by NMDA-receptor modulation. Trends Neurosci 25:474–480

    Article  PubMed  CAS  Google Scholar 

  • Lipton SA (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov 5:160–170

    Article  PubMed  CAS  Google Scholar 

  • Long J, Gao H, Sun L, Liu J, Zhao-Wilson X (2009) Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila Parkinson’s disease model. Rejuvenation Res 12:321–331

    Article  PubMed  CAS  Google Scholar 

  • Lopez-Miranda J, Delgado-Lista J, Perez-Martinez P, Jimenez-Gómez Y, Fuentes F, Ruano J, Marin C (2007) Olive oil and the haemostatic system. Mol Nutr Food Res 51:1249–1259

    PubMed  CAS  Google Scholar 

  • Love R (2001) Ethnic labels may not predict individuals’ responses to drugs. Lancet 358(9292):1519

    Article  PubMed  CAS  Google Scholar 

  • Lu B (2003) BDNF and activity-dependent synaptic modulation. Learn Mem 10:86–98

    Article  PubMed  Google Scholar 

  • Luchsinger JA, Noble JM, Scarmeas N (2007) Diet and Alzheimer’s disease. Curr Neurol Neurosci Rep 7:366–372

    Article  PubMed  CAS  Google Scholar 

  • Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115:2774–2783

    Article  PubMed  CAS  Google Scholar 

  • Lukiw WJ, Zhao Y, Cui JG (2008) An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 283:31315–31322

    Article  PubMed  CAS  Google Scholar 

  • Ma T, Zhao Y, Kwak YD, Yang Z, Thompson R, Luo Z, Xu H, Liao FF (2009a) Statin’s excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling. J Neurosci 29:11226–11236

    Article  PubMed  CAS  Google Scholar 

  • Ma QL, Yang F, Rosario ER, Ubeda QJ, Beech W, Gant DJ, Chen PP, Hudspeth B, Chen C, Zhao Y, Vinters HV, Frautchy SA, Cole GM (2009b) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29:9078–9089

    Article  PubMed  CAS  Google Scholar 

  • Mancuso M, orsucci D, Volpi L, Calsolaro V, Siciliano G (2010) Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Curr Drug Targets 11:111–121

    Article  PubMed  CAS  Google Scholar 

  • Mans RA, Chowdhury N, Cao D, McMahon LL, Li L (2010) Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice. Neuroscience 166:435–444

    Article  PubMed  CAS  Google Scholar 

  • Martin LJ, Gertz B, Pan Y, Price AC, Molkentin JD, Chang Q (2009) The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Exp Neurol 218:333–346

    Article  PubMed  CAS  Google Scholar 

  • Marvanova M, Lakso M, Pirhonen J, Nawa H, Wong G, Castren E (2001) The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci 18:247–258

    Article  PubMed  CAS  Google Scholar 

  • Mattson MP (2008) Awareness of hormesis will enhance future research in basic and applied neuroscience. Crit Rev Toxicol 38:633–639

    Article  PubMed  CAS  Google Scholar 

  • May BCH, Fafarman AT, Hong SB, Rogers M, Deady LW, Prusiner SB, Cohen FE (2003) Potent inhibition of scrapie prion replication in cultured cells by bis-acridines. Proc Natl Acad Sci USA 100:3416–3421

    Article  PubMed  CAS  Google Scholar 

  • McGuinness B, Craig D, Bullock R, Passmore P (2009) Statins for the prevention of dementia. Cochrane Database Syst Rev 2:CD003160

    PubMed  Google Scholar 

  • Menendez-Gonzalez M, Calatayud MT, Blazquez-Menes B (2005) Exacerbation of Lewy bodies dementia due to memantine. J Alzheimer Dis 8:289–291

    CAS  Google Scholar 

  • Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA (2004) Axonal neuregulin-1 regulates myelin sheath thickness. Science 304:700–703

    Article  PubMed  CAS  Google Scholar 

  • Milhavet O, McMahon HE, Rachidi W, Nishida N, Katamine S, Mange A, Arlotto M, Casanova D, Riondel J, Favier A, Lehmann S (2000) Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci USA 97:13937–13942

    Article  PubMed  CAS  Google Scholar 

  • Minguez-Castellanos A, Escamilla-Sevilla F (2005) Cell therapy and other neuroregenerative strategies in Parkinson’s disease (I). Rev Neurol 41:604–614

    PubMed  CAS  Google Scholar 

  • Mochizuki H (2009) Current status of gene therapy for Parkinson disease. Brain Nerve 61:485–493

    PubMed  CAS  Google Scholar 

  • Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, Aggarwal N, Schneider J (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60:940–946

    Article  PubMed  Google Scholar 

  • Muller-Schiffmann A, Korth C (2008) Vaccine approaches to prevent and treat prion infection: progress and challenges. BioDrugs 22:45–52

    Article  PubMed  Google Scholar 

  • Munoz-Torrero D (2008) Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer’s disease. Curr Med Chem 15:2433–2455

    Article  PubMed  CAS  Google Scholar 

  • Muntané G, Janué A, Fernandez N, Odena MA, Oliveira E, Boluda S, Portero-Otin M, Naudí A, Boada J, Pamplona R, Ferrer I (2010) Modification of brain lipids but not phenotype in alpha-synucleinopathy transgenic mice by long-term dietary n-3 fatty acids. Neurochem Int 12 Nov 2009 [Epub ahead of print]

    Google Scholar 

  • Murck H, Manku M (2007) Ethyl-EPA in Huntington disease: potentially relevant mechanism of action. Brain Res Bull 72:159–164

    Article  PubMed  CAS  Google Scholar 

  • Murer MG, Yan Q, Raisman-Vozari R (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol 63:71–124

    Article  PubMed  CAS  Google Scholar 

  • Mutez E, Duhamel A, Defebvre L, Bordet R, Destée A, Kreisler A (2009) Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson’s disease. Pharmacol Res 60:41–45

    Article  PubMed  CAS  Google Scholar 

  • Nakamura T, Lipton SA (2007) S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding. Cell Death Differ 14:1305–1314

    Article  PubMed  CAS  Google Scholar 

  • Nguyen T, Hamby A, Massa SM (2005) Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington’s disease mouse model. Proc Natl Acad Sci USA 102:11840–11845

    Article  PubMed  CAS  Google Scholar 

  • Nitschke C, Fiechsig E, van den Brandt J, Lindner N, Luhrs T, Dittmer U, Klein MA (2007) Immunisation strategies against prion diseases: prime-boost immunisation with a PrP DNA vaccine containing foreign helper T-cell epitopes does not prevent mouse scrapie. Vet Microbiol 123:367–376

    Article  PubMed  CAS  Google Scholar 

  • Nordberg A (1999) PET studies and cholinergic therapy in Alzheimer’s disease. Rev Neurol (Paris) 155(Suppl 4):S53–S63

    Google Scholar 

  • Nunomura A, Moreira PI, Lee HG, Zhu X, Castellani RJ, Smith MA, Perry G (2007) Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol Disord Drug Targets 6:411–423

    Article  PubMed  CAS  Google Scholar 

  • Origlia N, Arancio O, Domenici L, Yan SS (2009) MAPK, beta-amyloid and synaptic dysfunction: the role of RAGE. Expert Rev Neurother 9:1635–1645

    Article  PubMed  CAS  Google Scholar 

  • Ozdinler PH, Macklis JD (2006) IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nat Neurosci 9:1371–1381

    Article  PubMed  CAS  Google Scholar 

  • Papadia S, Soriano FX, Léveillé F, Martel MA, Dakin KA, Hansen HH, Kaindl A, Sifringer M, Fowler J, Stefovska V, McKenzie G, Craigon M, Corriveau R, Ghazal P, Horsburgh K, Yankner BA, Wyllie DJ, Ikonomidou C, Hardingham GE (2008) Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci 11:476–487

    Article  PubMed  CAS  Google Scholar 

  • Park S, Kim HT, Yun S, Kim IS, Lee J, Lee IS, Park KI (2009) Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice. Exp Mol Med 41:487–500

    Article  PubMed  CAS  Google Scholar 

  • Parsons RB, Price GC, Farrant JK, Subramaniam D, Adeagbo-Sheikh J, Austen BM (2006) Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms. Biochem J 399:205–214

    Article  PubMed  CAS  Google Scholar 

  • Patel NK, Gill SS (2007) GDNF delivery for Parkinson’s disease. Acta Neurochir Suppl 97:135–154

    Article  PubMed  CAS  Google Scholar 

  • Pedrini S, Carter TL, Prendergast G, Petanceska S, Ehrlich ME, Gandy S (2005) Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. PLoS Med 2:e18

    Article  PubMed  CAS  Google Scholar 

  • Pelleymounter MA, Cullen MJ, Baker MB, Gollub M, Wellman C (1996) The effects of intrahippocampal BDNF and NGF on spatial learning in aged Long Evans rats. Mol Chem Neuropathol 29:211–226

    Article  PubMed  CAS  Google Scholar 

  • Peng Y, Lee DY, Jiang L, Ma Z, Schachter SC, Lemere CA (2007) Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695. Neuroscience 150:386–395

    Article  PubMed  CAS  Google Scholar 

  • Perry G, Smith MA (2000) Promise and pitfalls of therapeutic to modify oxidant balance in chronic diseases. IDrugs 3:371–372

    PubMed  CAS  Google Scholar 

  • Peterson AL, Nutt JG (2008) Treatment of Parkinson’s disease with trophic factors. Neurotherapeutics 5:270–280

    Article  PubMed  CAS  Google Scholar 

  • Petri S, Kiaei M, Damiano M, Hiller A, Wille E, Manfredi G, Calingasan NY, Szeto HH, Beal MF (2006) Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. J Neurochem 98:1141–1148

    Article  PubMed  CAS  Google Scholar 

  • Planells-Cases R, Lerma J, Ferrer-Montiel A (2006) Pharmacological intervention at ionotropic glutamate receptor complexes. Curr Pharm Des 12:3583–3596

    Article  PubMed  CAS  Google Scholar 

  • Postina R (2008) A closer look at alpha-secretase. Curr Alzheimer Res 5:179–186

    Article  PubMed  CAS  Google Scholar 

  • Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol 45:358–368

    Article  PubMed  CAS  Google Scholar 

  • Poon WW, Blurton-Jones M, Tu CH, Feinberg LM, Chabrier MA, Harris JW, Jeon NL, Cotman CW (2009) Beta-Amyloid impairs axonal BDNF retrograde trafficking. Neurobiol Aging 18 Jun 2009 [Epub ahead of print]

    Google Scholar 

  • Priller C, Dewachter I, Vassallo N, Paluch S, Pace C, Kretzschmar HA, van Leuven F, Herms J (2007) Mutant Clioquinol 1 alters synaptic transmission in cultured hippocampal neurons. J Biol Chem 282:1119–1127

    Article  PubMed  CAS  Google Scholar 

  • Puri BK (2005) Treatment of Huntington’s disease with eicosapentaenoic acid. In: Yehuda S, Mostofsky DI (eds) Nutrients, stress and medical disorders. Nutrition and health (Series). Humana Press Inc, Totowa, NJ, pp 279–286

    Google Scholar 

  • Qiu C, Kivipetto M, von Strauss E (2009) Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11:111–128

    PubMed  Google Scholar 

  • Quinn LP, Crook B, Hows ME, Vidgeon-Hart M, Chapman H, Upton N, Medhurst AD, Virley DJ (2008) Br J Pharmacol 154:226–233

    Article  PubMed  CAS  Google Scholar 

  • Rahman I, MacNee W (2000) Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 28:1405–1420

    Article  PubMed  CAS  Google Scholar 

  • Ramaswamy S, Soderstrom KE, Kordower JH (2009) Trophic factors therapy in Parkinson’s disease. Prog Brain Res 175:201–216

    Article  PubMed  CAS  Google Scholar 

  • Rammes G, Rupprecht R, Ferrari U, Zieglgänsberger W, Parsons CG (2001) The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett 306:81–84

    Article  PubMed  CAS  Google Scholar 

  • Ray B, Banerjee PK, Geig NH, Lahiri DK (2009) Memantine treatment decreases levels of secreted Alzheimer’s amyloid precursor protein (APP) and amyloid beta (Abeta) peptide in the human neuroblastoma cells. Neurosci Lett [Epub ahead of print]

    Google Scholar 

  • Reddy PH (2008) Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Med 10:291–315

    Article  PubMed  CAS  Google Scholar 

  • Reddy PH, Mao P, Manczak M (2009) Mitochondrial structural and functional dynamics in Huntington’s disease. Brain Res Rev 61:33–48

    Article  PubMed  CAS  Google Scholar 

  • Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ Memantine Study Group (2003) Memantine in moderate-to-severe Alzheimer’s disease. N Engl J Med 348:1333–1341

    Article  PubMed  CAS  Google Scholar 

  • Riekse RG, Li G, Petrie EC, Leverenz JB, Vavrek D, Vuletic S, Albers JJ, Montine TJ, Lee VM, Lee M, Seubert P, Galasko D, Schellenberg GD, Hazzard WR, Peskind ER (2006) Effect of statins on Alzheimer’s disease biomarkers in cerebrospinal fluid. J Alzheimer Dis 10:399–406

    CAS  Google Scholar 

  • Ridha BH, Josephs KA, Rosser MN (2005) Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine. Neurology 65:481–482

    Article  PubMed  CAS  Google Scholar 

  • Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND (2006) Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 55:928–934

    Article  PubMed  CAS  Google Scholar 

  • Robson LG, Dyalls S, Sidloff D, Michael-Titus AT (2008) Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. Neurobiol Aging 10 Jly [Epub a head print]

    Google Scholar 

  • Rogawski MA, Wenk GL (2003) The neuropharmacological basis for the use of memantine in the treatment of Alzheimer’s disease. CNS Drug Rev 9:275–308

    Article  PubMed  CAS  Google Scholar 

  • Romrell J, Fernandez HH, Okun MS (2003) Rationale for current therapies in Parkinson’s disease. Exp Opin Pharmacother 4:1747–1761

    Article  CAS  Google Scholar 

  • Sakaguchi S (2009) Systematic review of the therapeutics for prion diseases. Brain Nerve 61:929–938

    PubMed  CAS  Google Scholar 

  • Sakowski SA, Schuyler AD, Feldman EL (2009) Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis. Amyyotroph Lateral Scler 10:63–73

    Article  CAS  Google Scholar 

  • Samadi P, Grégoire L, Rouillard C, Bédard PJ, Di Paolo T, Lévesque D (2006) Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Ann Neurol 59:282–288

    Article  PubMed  CAS  Google Scholar 

  • Sanchez I, Mahlke C, Yuan J (2003) Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421:373–379

    Article  PubMed  CAS  Google Scholar 

  • Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL, Webster JA, Lewis TA, O‘Kane CJ, Schreiber SL, Rubinsztein DC (2007) Small molecules enhance autophagy and reduce toxicity in Huntington’s disease models. Nat Chem Biol 3:331–338

    Article  PubMed  CAS  Google Scholar 

  • Sarkar S, Krishna G, Imarisio S, Saiki S, O’Kane CJ, Rubinsztein DC (2008) A rational mechanism for combination treatment of Huntington’s disease using lithium and rapamycin. Hum Mol Genet 17:170–178

    Article  PubMed  CAS  Google Scholar 

  • Sastre M, Dewachter I, Rossner S (2006a) Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma. Proc Natl Acad Sci USA 103:443–448

    Article  PubMed  CAS  Google Scholar 

  • Sastre M, Klockgether T, Heneka MT (2006b) Contribution of inflammatory processes to Alzheimer’s disease: molecular mechanisms. Int J Dev Neurosci 24:167–176

    Article  PubMed  CAS  Google Scholar 

  • Saydoff JA, Garcia RA, Browne SE, Liu L, Sheng J, Brenneman D, Hu Z, Cardin S, Gonzalez A, von Borstel RW, Gregorio J, Burr H, Beal MF (2006) Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171–82Q mouse models of Huntington’s disease. Neurobiol Dis 24:455–465

    Article  PubMed  CAS  Google Scholar 

  • Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA (2006) Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham heart study. Arch Neurol 63:1545–1550

    Article  PubMed  Google Scholar 

  • Schmitt FA, van Dyck CH, Wichems CH, Olin JT For the Memantine MEM-MD-02 Study Group (2006) Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis. Alzheimer Dis Assoc Disord 20:255–262

    Article  PubMed  CAS  Google Scholar 

  • Schmitt F, Ryan M, Cooper G (2007) A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer’s disease. Expert Opin Drug Metab Toxicol 3:135–141

    Article  PubMed  CAS  Google Scholar 

  • Schuster S, Nadjar A, Guo JT, Li Q, Ittrich C, Hengerer B, Bezard E (2008) The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson’s disease. J Neurosci 28:4311–4316

    Article  PubMed  CAS  Google Scholar 

  • Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741–766

    PubMed  CAS  Google Scholar 

  • Serhan CN (2005) Novel ω-3-derived local mediators in anti-inflammation and resolution. Pharmacol Ther 105:7–21

    Article  PubMed  CAS  Google Scholar 

  • Sezeto HH (2006) Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J 8:E521–E531

    Article  Google Scholar 

  • Sharma S, Prasanthi RPJ, Schommer E, Feist G, Ghribi O (2008) Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Neurobiol Dis 32(3):426–432

    Article  PubMed  CAS  Google Scholar 

  • Shen WH, Zhang CY, Zhang GY (2003) Antioxidants attenuate reperfusion injury after global brain ischemia through inhibiting nuclear factor-kappa B activity in rats. Acta Pharmacol Sin 24:1125–1130

    PubMed  CAS  Google Scholar 

  • Siman R, Salidas S (2004) γ-secretase subunit composition and distribution in the presenilin wild-type and mutant mouse brain. Neuroscience 129:615–628

    Article  PubMed  CAS  Google Scholar 

  • Singh P, Suman S, Chandna S, Das TK (2009) Possible role of amyloid-beta, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial dysfunction of Alzheimer’s disease. Bioinformation 3:440–445

    Article  PubMed  Google Scholar 

  • Smith KM, Matson S, Matson WR, Cormier K, Del Signore SJ, Hagerty SW, Stack EC, Ryu H, Ferrante RJ (2006) Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington’s disease mice. Biochim Biophys Acta 1762:616–626

    Article  PubMed  CAS  Google Scholar 

  • Sofi F, Cesari F, Abbate R, Gensini GF, Casini A (2008) Adherence to Mediterranean diet and health status: meta-analysis. Br Med J 337:a1334

    Google Scholar 

  • Song SM, Rauw G, Baker GB, Kar S (2008) Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Eur J Neurosci 28:1989–2002

    Article  PubMed  CAS  Google Scholar 

  • Sonkusare SK, Kaul CL, Ramarao P (2005) Dementia of Alzheimer’s disease and other neurodegenerative disorders–memantine, a new hope. Pharmacol Res 51:1–17

    Article  PubMed  CAS  Google Scholar 

  • Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J, Ziolkowski C (2005) Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD. Curr Alzheimer Res 2:343–353

    Article  PubMed  CAS  Google Scholar 

  • Spires TL, Hannan A (2005) Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw. FASEB J 272:2347–2361

    CAS  Google Scholar 

  • Stack EC, Smith KM, Ryu H, Cormier K, Chen M, Hagerty SW, Del Signore SJ, Cudkowicz ME, Friedlander RM, Ferrante RJ (2006) Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington’s disease mice. Biochim Biophys Acta 1762:373–380

    Article  PubMed  CAS  Google Scholar 

  • Stewart LR, White AR, Jobling MF, Needham BE, Maher F, Thyer J, Beyreuther K, Masters CL, Collins SJ, Cappai R (2001) Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106–126. J Neurosci Res 65:565–572

    Article  PubMed  CAS  Google Scholar 

  • Sullivan PG, Rabchevsky AG, Waldmeier PC, Spiringer JE (2005) J. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? Neurosci Res 79:231–239

    Article  CAS  Google Scholar 

  • Tan DX, Manchester LC, Sainz R, Mayo JC, Alvares FL, Reiter RJ (2003) Antioxidant strategies in protection against neurodegenerative disorders. Expert Opin Ther Patents 13:1513–1543

    Article  CAS  Google Scholar 

  • Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, Doi H, Kurosawa M, Nekooki M, Nukina N (2004) Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med 10:148–154

    Article  PubMed  CAS  Google Scholar 

  • Tarawneh R, Holtzman DM (2009) Critical issues for successful immunotherapy in Alzheimer’s disease: development of biomarkers and methods for early detection and intervention. CNS Neurol Disord Drug Targets 8:144–159

    Article  PubMed  CAS  Google Scholar 

  • Todd NV, Morrow J, Doh-Ura K, Dealler S, O’Hare S, Farling P, Duddy M, Rainov NG (2005) Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease. J Infect 50:394–396

    Article  PubMed  CAS  Google Scholar 

  • Tomita T (2009) Alzheimer’s disease treatment by inhibition/modulation of the gamma-secretase activity. Rinsho Shinkeigaku 49:845–847

    Article  PubMed  Google Scholar 

  • Townsend L, Ongini E, Wenk G (2004) Novel therapeutic opportunities for Alzheimer’s disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J 19:1592–1601

    Article  CAS  Google Scholar 

  • Trejo JL, Carro E, Nunez A, Torres-Aleman I (2002) Sedentary life impairs self-reparative processes in the brain: the role of serum insulin-like growth factor-I. Rev Neurosci 13:365–374

    PubMed  CAS  Google Scholar 

  • Tsuboi Y, Doh-ura K, Yamada T (2009) Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases. Neuropathology 29(5):632–636

    Article  PubMed  Google Scholar 

  • Tsujimoto Y, Shimizu S (2003) Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12:835–840

    Article  CAS  Google Scholar 

  • Turnbull S, Tabner BJ, Brown DR, Allsop D (2003) Quinacrine acts as an antioxidant and reduces the toxicity of the prion peptide PrP106–126. NeuroReport 14:1743–1745

    Article  PubMed  CAS  Google Scholar 

  • Urosevic N, Martin RN (2008) Infection and Alzheimer’s disease: the APOE epsilon4 connection and lipid metabolism. J Alzheimer Dis 13:421–435

    CAS  Google Scholar 

  • Urushitani M (2009) Future perspectives of immunotherapy against ALS. Rinsho Shinkeigaku 49:818–820

    Article  PubMed  Google Scholar 

  • Valverde G, De Andrade D, Madureira de Oliveria D, Barreto G, Bertolino LA, Saraceno E, Capani F, Giraldez LD (2008) Effects of the extract of Anemopaegma mirandum (Catuaba) on Rotenone-induced apoptosis in human neuroblastomas SH-SY5Y cells. Brain Res 1198:188–196

    Article  CAS  Google Scholar 

  • Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, et al (1999) β-Secretase cleavage of Alzheimer’s amyloid precursor protein by transmembrane aspartic protease BACE. Science 286:735–741

    Article  PubMed  CAS  Google Scholar 

  • Vaughan CJ (2003) Prevention of stroke and dementia with statins: effects beyond lipid lowering. Am J Cardiol 91:23B–29B

    Article  PubMed  CAS  Google Scholar 

  • Vaynman S, Ying Z, Gomez-Pinilla F (2004) Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci 20:2580–2590

    Article  PubMed  Google Scholar 

  • Vaynman S, Gomez-Pinilla F (2006) Revenge of the “sit”: how lifestyle impacts neuronal and cognitive health through molecular systems that interface energy metabolism with neuronal plasticity. J Neurosci Res 84:699–715

    Article  PubMed  CAS  Google Scholar 

  • Vaynman S, Ying Z, Wu A, Gomez-Pinilla F (2006) Coupling energy metabolism with a mechanism to support brain-derived neurotrophic factor-mediated synaptic plasticity. Neuroscience 139:1221–1234

    Article  PubMed  CAS  Google Scholar 

  • Vogtherr M, Grimme S, Elshorst B, Jacobs DM, Fiebig K, Griesinger C, Zahn R (2003) Antimalarial drug quinacrine binds to C-terminal helix of cellular prion protein. J Med Chem 46:3563–3564

    Article  PubMed  CAS  Google Scholar 

  • Vulih-Shutzman I, Pinhasov A, Mandel S, Grigoriadis N, Touloumi O, Pittel Z, Gozes I (2007) Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. J Pharmacol Exp Ther 323:438–449

    Article  CAS  Google Scholar 

  • Waldmeier PC, Zimmermann K, Qian T, Tintelnot-Blomley M, Lemasters JJ (2003) Cyclophilin D as a drug target. Curr Med Chem 10:1485–1506

    Article  PubMed  CAS  Google Scholar 

  • Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM (2003) Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington’s disease. Proc Natl Acad Sci USA 100:10483–10487

    Article  PubMed  CAS  Google Scholar 

  • Wang R, Tang XC (2005) Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer’s disease. Neurosignals 14:71–82

    Article  PubMed  CAS  Google Scholar 

  • Wang R, Zhang D (2005) Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model. Eur J Neurosci 22:2376–2380

    Article  PubMed  Google Scholar 

  • Wang JY, Wen LL, Huang YN, Chen YT, Ku MC (2006) Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr Pharmaceut Des 12:3521–3533

    Article  CAS  Google Scholar 

  • Wang J, Zhang HY, Tang XC (2010) Huperzine A improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion. J Neurosci Res 88:807–815

    PubMed  CAS  Google Scholar 

  • Wenk GL, Parsons CG, Danysz W (2006) Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine. Behav Pharmacol 17:411–424

    Article  PubMed  CAS  Google Scholar 

  • White AR, Hawke SH (2003) Immunotherapy as a therapeutic treatment for neurodegenerative disorders. J Neurochem 87:801–808

    Article  PubMed  CAS  Google Scholar 

  • Wilczak N, de Keyser J (2005) Insulin-like growth factor system in amyotrophic lateral sclerosis. Endocr Dev 9:160–169

    Article  PubMed  CAS  Google Scholar 

  • Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, DeStrooper B, Saftig P, Birchmeier C, Haass C (2006) Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314:664–666

    Article  PubMed  CAS  Google Scholar 

  • Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, Jahreiss L, Fleming A, Pask D, Goldsmith P, O‘Kane CJ, Floto RA, Rubinsztein DC (2008) Novel targets for Huntington’s disease in an mTOR-independent autophagy pathway. Nat Chem Biol 4:295–305

    Article  PubMed  CAS  Google Scholar 

  • Wolozin B (2002) Cholesterol and Alzheimer’s disease. Biochem Soc Trans 30:525–529

    Article  PubMed  CAS  Google Scholar 

  • Wong HK, Bauer PO, Kurosawa M, Goswami A, Washizu C, Machida Y, Tosaki A, Yamada M, Knöpfel T, Nakamura T, Nukina N (2008) Blocking acidsensing ion channel 1 alleviates Huntington’s disease pathology via an ubiquitin-proteasome system-dependent mechanism. Hum Mol Genet 17:3223–3235

    Article  PubMed  CAS  Google Scholar 

  • Wu TY, Chen CP (2009) Dual action of memantine in Alzheimer disease: a hypothesis. Taiwan J Obstet Gynecol 48:273–277

    Article  PubMed  Google Scholar 

  • Wu HM, Tzeng NS, Qian L, Wei SJ, Hu X, Chen SH, Rawls SM, Flood P, Hong JS, Lu RB (2009) Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. Neuropsychopharmacology 34:2344–2357

    Article  PubMed  CAS  Google Scholar 

  • Yamamoto A, Lucas JJ, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington’s disease. Cell 101:57–66

    Article  PubMed  CAS  Google Scholar 

  • Zhang HY, Yan H, Tang XC (2008) Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase. Cell Mol Neurobiol 28:173–183

    Article  PubMed  CAS  Google Scholar 

  • Zhou J, Tang XC (2002) Huperzine A attenuates apoptosis and mitochondria-dependent caspase-3 in rat cortical neurons. FEBS Lett 526:21–25

    Article  PubMed  CAS  Google Scholar 

  • Zhou J, Yi J, Fu R, Liu E, Siddique T, Ríos E, Deng HX (2010) Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis. J Biol Chem 285:705–712

    Article  PubMed  CAS  Google Scholar 

  • Zimmermann M, Gardoni F, Di Luca M (2005) Molecular rationale for the pharmacological treatment of Alzheimer’s disease. Drugs Aging 22(Suppl 1):27–37

    Article  PubMed  CAS  Google Scholar 

  • Zona C, Siniscalchi A, Mercuri NB, Bernardi G (1998) Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons. Neuroscience 85:931–938

    Article  PubMed  CAS  Google Scholar 

  • Zu T, Duvick LA, Kaytor MD, Berlinger MS, Zoghbi HY, Clark HB, Orr HT (2004) Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. J Neurosci 24:8853–8861

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Cellular Biochemistry, The Ohio State University, 1645 Neil Avenue, Columbus, OH, 43210, USA

    Akhlaq A. Farooqui

Authors
  1. Akhlaq A. Farooqui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akhlaq A. Farooqui .

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Farooqui, A.A. (2010). Potential Therapeutic Strategies for Neurodegenerative Diseases. In: Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6652-0_9

Download citation

Publish with us

Policies and ethics

Search

Navigation